Syndicate Bio
Empowering Personalized Healthcare and Advancing Precision Medicine
Newark, United States · Founded 2024 · $120K raised
- Headquarters
- Newark, Delaware
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- syndicatebio.com
- Total Funding
- $120K
- Last Round
- $120K SeedSep 2024
- Rounds
- 1
About
Syndicate Bio is a genomics and precision medicine company building Africa's largest genomic reference database to bridge the data gap in precision medicine. The company offers genetic testing services including hereditary cancer screening, non-invasive prenatal testing (NIPT), somatic cancer testing, and pharmacogenomic testing. Operating through its 'Direct by Syndicate Bio' consumer brand, the company brings world-class genetic testing directly to individuals, families, and healthcare providers across Africa.
Summary
Syndicate Bio is a Healthcare company based in Newark, United States, founded in 2024. It has raised $120K in total across 1 round, most recently a $120K Seed round in Sep 2024. Investors include Techstars.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe